Results 101 to 110 of about 29,282 (210)
Update on fosfomycin-modified genes in Enterobacteriaceae
The long-used antibiotic fosfomycin has recently been re-evaluated as a potential regimen for treating extended-spectrum β-lactamases (ESBLs) and carbapenem-resistant Enterobacteriaceae (CRE).
Tsung-Ying Yang +2 more
doaj +1 more source
An Efficient, One-Pot Synthesis of Fosfomycin Dialkyl Esters from (R)-2-Tosyloxypropanal [PDF]
(R)-2-Tosyloxypropanal (4) was prepared from D-mannitol in a 7-step sequence (51% overall yield). Addition of dialkyl phosphonates to 4 in the presence of titanium isopropoxide and the subsequent treatment with DBU stereoselectively afforded, in one-pot,
Hanaya, Tadashi +2 more
core +1 more source
A series of vancomycin‐antimicrobial peptide conjugates is synthesized and evaluated to identify the optimal combination. Vm‐MSI, selected from multiple candidates, exhibited potent activity against vancomycin‐resistant and Gram‐negative bacteria by disrupting membranes and inducing oxidative stress, thereby expanding vancomycin's antibacterial ...
Shuangyu Li +7 more
wiley +1 more source
Fosfomycin: A First-Line Oral Therapy for Acute Uncomplicated Cystitis
Fosfomycin is a new agent to Canada approved for the treatment of acute uncomplicated cystitis (AUC) in adult women infected with susceptible isolates of E. coli and Enterococcus faecalis.
George G. Zhanel +2 more
doaj +1 more source
Fosfomycin susceptibility of uropathogens at Charlotte Maxeke Johannesburg Academic Hospital
Background: Multidrug-resistant uropathogens are becoming widespread both in community and hospital setting. Safe yet effective treatments are a priority.
Lesego M. Mothibi +2 more
doaj +1 more source
Exploring dangerous connections between Klebsiella pneumoniae biofilms and healthcare-associated infections [PDF]
Healthcare-associated infections (HAI) are a huge public health concern,particularly when the etiological agents are multidrug resistant. The ability of bacteria to develop biofilm is a helpful skill, both to persist within hospital units and to ...
Bandeira, Maria +3 more
core +2 more sources
Lemierre's Syndrome Caused by Klebsiella pneumoniae: Case Report and Review of the Literature
Axial contrast‐enhanced chest CT demonstrating multiple peripheral cavitary nodules and consolidations, predominantly in the right lower lobe, consistent with septic pulmonary emboli (arrows). ABSTRACT Klebsiella pneumoniae is an uncommon but increasingly recognized cause of Lemierre's syndrome, a condition classically associated with Fusobacterium ...
Abril Aguilar Guerrero +1 more
wiley +1 more source
Objectives: The increasing emergence and diffusion of multidrug-resistant (MDR) pathogenic bacteria, both in hospital and community settings, is inducing clinicians to reconsider old antibiotics, such as fosfomycin, to overcome the difficulties posed by ...
Ausilia Aprile +3 more
doaj +1 more source
TeHyperBTM is introduced as a highly nucleophilic chiral Lewis basic organocatalyst that allows for asymmetric (4 + 2)‐cycloadditions of allenoates and Michael acceptors, where its analogous S‐ and Se‐variants come to their limits. TeHyperBTM [= (2S,3R)‐3‐isopropyl‐2‐phenyl‐3,4‐dihydro‐2H‐benzo[4,5][1,3]tellurazolo[3,2‐a]pyrimidine] is introduced as a ...
Magdalena Piringer +6 more
wiley +1 more source
: Objective: To evaluate the efficacy of high-dose intravenous fosfomycin for the treatment of urinary tract infections (UTI) caused by KPC carbapenemase-producing Klebsiella pneumoniae (KPC-Kp).
Jorge Rodríguez-Gómez +14 more
doaj +1 more source

